Stephanie M. Hare, PhD

University of Wisconsin Madison, BS 2009 (Neurobiology)

Loyola University Chicago, MA 2012 (Philosophy; Specialization: Ethics, Neuroethics)

Georgia State University, MA 2016 (Neuroscience)

Georgia State University, PhD 2018 (Neuroscience; concentration: Neuroethics)

Dr. Hare is a neuroscientist using functional magnetic resonance imaging (fMRI) analyses as a window to understand how brain excitability becomes altered in schizophrenia with a specialization in investigating networks underlying hallucinations. Transcranial magnetic stimulation (TMS) is a cutting-edge tool that can be used to normalize neural circuit function and may provide a new window to better understand altered brain excitability in schizophrenia and its relationship to symptoms. Dr. Hare is interested in combining TMS and fMRI approaches to better understand cognitive impairments, a historically underserved treatment target in the field of schizophrenia research. Given her extensive training in ethics, Dr. Hare also has interests in the ethical, legal and social implications of psychiatric practices and policies, in addition to neuroscience technologies including fMRI, TMS and artificial intelligence/machine learning. She is currently co-leading a working group on ethics of AI (https://www.neuroethicssociety.org/ai-consciousness-group).

schizophrenia, hallucinations, functional magnetic resonance imaging (fMRI), transcranial magnetic stimulation (TMS)

Hare, SM., Benzer, S., Knight, S., Rakhshan Rouhakhtar, P., Reeves, G., McDonald, K., RachBeisel, J. Virtual Civil Commitment Hearings: Convenience at the Costs of Compromised Communication & Safety Assessments. Psychiatric Services. 2023 Nov 14; https://doi.org/10.1176/appi.ps.20230217

Hare, SM, Adhikari, BM, Mo, C, Chen, S, Wijtenburg, SA, Seneviratne, C, Kane-Gerard, S, Sathyasaikumar, KV, Notarangelo, FM, Schwarcz, R, Rowland, LM, Kelly, DL, Buchanan, RW. Tryptophan Challenge in Individuals with Schizophrenia and Healthy Controls: Acute Effects on Circulating Kynurenine and Kynurenic Acid, Cognition and Cerebral Blood Flow. Neuropsychopharmacology. 2023. doi: 10.1038/s41386-023-01587-3

Hare SM. Hallucinations: A Functional Network Model of How Sensory Representations Become Selected for Conscious Awareness in Schizophrenia. Front Neurosci. 2021 Nov 23;15:733038. doi: 10.3389/fnins.2021.733038. PMID: 34887720; PMCID: PMC8650055.

Hare, S.M., Du, X., Adhikari, B.M., Garcia, L., Bruce, H., Kochunov, P., Hong, L.E. Mapping Local and Long-Distance Resting Connectivity Markers of TMS-Related Inhibition Deficits in Schizophrenia. Neuroimage Clin 2021 Apr 30; 31:102688.